CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZNCF

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
AZNCFPhase 2

Tremelimumab Phase 2 Est. Readout

Tremelimumab
Q3 2027~Q
CT.gov
00%
Dec '26
AZNCFPhase 2

Tremelimumab Phase 2 Est. Readout

Tremelimumab
Dec 2026~
CT.gov
00%
Competitive Landscape

2 competitors in Non Small Cell Lung Cancer NSCLC

View Full Landscape
Drug Information

Target Indication

Non Small Cell Lung Cancer NSCLC

Clinical Trial

NCT03164616

Last updated: 2/25/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.